HK1050693A1 - Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them. - Google Patents

Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them.

Info

Publication number
HK1050693A1
HK1050693A1 HK03102864A HK03102864A HK1050693A1 HK 1050693 A1 HK1050693 A1 HK 1050693A1 HK 03102864 A HK03102864 A HK 03102864A HK 03102864 A HK03102864 A HK 03102864A HK 1050693 A1 HK1050693 A1 HK 1050693A1
Authority
HK
Hong Kong
Prior art keywords
ribitol
ribose
phosphate
vaccines containing
oligosaccharides derived
Prior art date
Application number
HK03102864A
Other languages
English (en)
Inventor
Vicente Guillermo Vere Bencomo
Rene Roy
Original Assignee
Univ La Habana
Univ Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ La Habana, Univ Ottawa filed Critical Univ La Habana
Publication of HK1050693A1 publication Critical patent/HK1050693A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08—Polyoxyalkylene derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
HK03102864A 1999-08-30 2003-04-23 Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them. HK1050693A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1999121A CU22904A1 (es) 1999-08-30 1999-08-30 Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
PCT/CU2000/000003 WO2001016146A1 (es) 1999-08-30 2000-08-15 Oligosacáridos derivados de ribosa-ribitol-fosfato y vacunas que los contienen

Publications (1)

Publication Number Publication Date
HK1050693A1 true HK1050693A1 (en) 2003-07-04

Family

ID=5459405

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03102864A HK1050693A1 (en) 1999-08-30 2003-04-23 Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them.

Country Status (24)

Country Link
US (1) US6765091B1 (xx)
EP (1) EP1212334B1 (xx)
JP (1) JP4850377B2 (xx)
KR (1) KR100818163B1 (xx)
CN (1) CN1205217C (xx)
AR (1) AR025435A1 (xx)
AT (1) ATE308551T1 (xx)
AU (1) AU780816B2 (xx)
BR (1) BRPI0013686B8 (xx)
CA (1) CA2382602C (xx)
CO (1) CO5180646A1 (xx)
CU (1) CU22904A1 (xx)
CZ (1) CZ2002721A3 (xx)
DE (1) DE60023722T2 (xx)
DK (1) DK1212334T3 (xx)
EA (1) EA005381B1 (xx)
ES (1) ES2252045T3 (xx)
HK (1) HK1050693A1 (xx)
MX (1) MXPA02002066A (xx)
NZ (1) NZ517464A (xx)
SI (1) SI1212334T1 (xx)
UA (1) UA75579C2 (xx)
WO (1) WO2001016146A1 (xx)
ZA (1) ZA200201667B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050169941A1 (en) * 2004-01-29 2005-08-04 Andrew Lees Use of amino-oxy functional groups in the preparation of protein-polysaccharide conjugate vaccines
WO2011017101A2 (en) 2009-07-27 2011-02-10 Fina Biosolutions, Llc Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
US9085610B2 (en) 2009-07-31 2015-07-21 National Research Council Of Canada H. pylori lipopolysaccharide outer core epitope
CA2836140C (en) 2009-12-17 2016-06-21 Fina Biosolutions, Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
AU2010351576B2 (en) * 2010-04-23 2014-08-14 FinaBioSolutions, LLC Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
SG11201811350QA (en) 2016-07-28 2019-01-30 Max Planck Gesellschaft Stable hydrolysis-resistant synthetic polyribosylribitolphosphate derivatives as vaccines against haemophilus influenzae type b
EP3768309A4 (en) * 2018-03-23 2021-12-01 Koranex Capital PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae

Also Published As

Publication number Publication date
JP2003528032A (ja) 2003-09-24
WO2001016146A1 (es) 2001-03-08
EA005381B1 (ru) 2005-02-24
CO5180646A1 (es) 2002-07-30
US6765091B1 (en) 2004-07-20
MXPA02002066A (es) 2004-07-30
CU22904A1 (es) 2004-01-23
CZ2002721A3 (cs) 2002-07-17
CN1376158A (zh) 2002-10-23
CA2382602C (en) 2010-02-16
CN1205217C (zh) 2005-06-08
BRPI0013686B8 (pt) 2021-05-25
UA75579C2 (en) 2006-05-15
AU780816B2 (en) 2005-04-21
DE60023722D1 (de) 2005-12-08
ATE308551T1 (de) 2005-11-15
EP1212334A1 (en) 2002-06-12
BR0013686A (pt) 2002-08-13
BRPI0013686B1 (pt) 2016-07-26
EP1212334B1 (en) 2005-11-02
AU6817300A (en) 2001-03-26
KR100818163B1 (ko) 2008-03-31
DE60023722T2 (de) 2006-07-20
DK1212334T3 (da) 2006-03-20
SI1212334T1 (sl) 2006-04-30
KR20020068501A (ko) 2002-08-27
EA200200314A1 (ru) 2002-10-31
AR025435A1 (es) 2002-11-27
ZA200201667B (en) 2003-08-27
CA2382602A1 (en) 2001-03-08
ES2252045T3 (es) 2006-05-16
JP4850377B2 (ja) 2012-01-11
NZ517464A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
MXPA01012635A (es) Dispositivos, sistemas y metodos para auxiliar al corazon.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
PL355109A1 (en) Tert.
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA200103880B (en) Catalyst.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200001665B (en) Suspension device.
HK1068100A1 (en) Bacillus anthracis exoantigens.
ZA200202537B (en) Pour-on-formulations.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
ZA200203707B (en) Pharmaceutical combinations.
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
ZA200200222B (en) Titanium derived compounds, preparation and use thereof.
ZA200110340B (en) Container.
HK1050693A1 (en) Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them.
MXPA01011720A (es) 3-piridil-4-arilpirroles sustituidos, y metodos terapeuticos y profilacticos relacionados.
ZA200110454B (en) Pharmaceutical complex.
ZA200006750B (en) Prosthesis System.
GB0029720D0 (en) I.S machine7544232001
MXPA01010701A (es) Vacuna.
ZA200109571B (en) Novel compounds, their use and preparation.
ZA200001747B (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.
MXPA02011191A (es) Vacunas, inmunoterapeuticos, y metodos de uso de los mismos.
EP1231266A4 (en) GDP-4-KETO-6-DEOXY-D-MANNOSE-3,5-EPIMERASE-4-REDUKTASEGENE FROM ARABIDOPSIS